Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis

被引:40
作者
Luo, Jiang-Yun [1 ,2 ,3 ]
Cheng, Chak Kwong [2 ,3 ,10 ]
He, Lei [2 ,3 ,10 ]
Pu, Yujie [2 ,3 ,10 ]
Zhang, Yang [6 ]
Lin, Xiao [5 ]
Xu, Aimin [7 ]
Lau, Chi Wai [2 ,3 ]
Tian, Xiao Yu [2 ,3 ]
Ma, Ronald Ching Wan [4 ]
Jo, Hanjoong [8 ,9 ]
Huang, Yu [10 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Inst Cardiovasc Dev & Regenerat Med, Bldg 3,Linqing Rd 450, Shanghai, Peoples R China
[2] Chinese Univ Hong Kong, Heart & Vasc Inst, Shenzhen Res Inst, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China
[6] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou, Guangdong, Peoples R China
[7] Univ Hong Kong, Dept Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China
[8] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA
[9] Emory Univ, Atlanta, GA 30322 USA
[10] City Univ & Long Kong, Dept Biomed Sci, 1A-108,1-F,Block 1,To Yuen Bldg, Hong Kong, Peoples R China
基金
中国国家自然科学基金;
关键词
antioxidants; atherosclerosis; endothelial cell; inflammation; resveratrol; KRUPPEL-LIKE FACTOR-2; ACTIVATED PROTEIN-KINASE; UNCOUPLING PROTEIN-2; VASCULAR ENDOTHELIUM; DISTURBED FLOW; TRANSCRIPTION; KLF2; DYSFUNCTION; INHIBITION; EXPRESSION;
D O I
10.1161/CIRCRESAHA.122.321187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Inflamed endothelial cells (ECs) trigger atherogenesis, especially at arterial regions experiencing disturbed blood flow. UCP2 (Uncoupling protein 2), a key mitochondrial antioxidant protein, improves endothelium-dependent relaxation in obese mice. However, whether UCP2 can be regulated by shear flow is unknown, and the role of endothelial UCP2 in regulating inflammation and atherosclerosis remains unclear. This study aims to investigate the mechanoregulation of UCP2 expression in ECs and the effect of UCP2 on endothelial inflammation and atherogenesis. Methods: In vitro shear stress simulation system was used to investigate the regulation of UCP2 expression by shear flow. EC-specific Ucp2 knockout mice were used to investigate the role of UCP2 in flow-associated atherosclerosis. Results: Shear stress experiments showed that KLF2 (Kruppel-like factor 2) mediates fluid shear stress-dependent regulation of UCP2 expression in human aortic and human umbilical vein ECs. Unidirectional shear stress, statins, and resveratrol upregulate whereas oscillatory shear stress and proinflammatory stimuli inhibit UCP2 expression through altered KLF2 expression. KLF2 directly binds to UCP2 promoter to upregulate its transcription in human umbilical vein ECs. UCP2 knockdown induced expression of genes involved in proinflammatory and profibrotic signaling, resulting in a proatherogenic endothelial phenotype. EC-specific Ucp2 deletion promotes atherogenesis and collagen production. Additionally, we found endothelial Ucp2 deficiency aggravates whereas adeno-associated virus-mediated EC-Ucp2 overexpression inhibits carotid atherosclerotic plaque formation in disturbed flow-enhanced atherosclerosis mouse model. RNA-sequencing analysis revealed FoxO1 (forkhead box protein O1) as the major proinflammatory transcriptional regulator activated by UCP2 knockdown, and FoxO1 inhibition reduced vascular inflammation and disturbed flow-enhanced atherosclerosis. We showed further that UCP2 level is critical for phosphorylation of AMPK (AMP-activated protein kinase), which is required for UCP2-induced inhibition of FoxO1. Conclusions: Altogether, our studies uncover that UCP2 is novel mechanosensitive gene under the control of fluid shear stress and KLF2 in ECs. UCP2 expression is critical for endothelial proinflammatory response and atherogenesis. Therapeutic strategies enhancing UCP2 level may have therapeutic potential against atherosclerosis.
引用
收藏
页码:424 / 441
页数:18
相关论文
共 57 条
[1]   Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis [J].
Atkins, G. Brandon ;
Wang, Yunmei ;
Mahabeleshwar, Ganapati H. ;
Shi, Hong ;
Gao, Huiyun ;
Kawanami, Daiji ;
Natesan, Viswanath ;
Lin, Zhiyong ;
Simon, Daniel I. ;
Jain, Mukesh K. .
CIRCULATION RESEARCH, 2008, 103 (07) :690-693
[2]   Pathophysiology and treatment of atherosclerosis Current view and future perspective on lipoprotein modification treatment [J].
Bergheanu, S. C. ;
Bodde, M. C. ;
Jukema, J. W. .
NETHERLANDS HEART JOURNAL, 2017, 25 (04) :231-242
[3]   Protective role of uncoupling protein 2 in atherosclerosis [J].
Blanc, J ;
Alves-Guerra, MC ;
Esposito, B ;
Rousset, S ;
Gourdy, P ;
Ricquier, D ;
Tedgui, A ;
Miroux, B ;
Mallat, Z .
CIRCULATION, 2003, 107 (03) :388-390
[4]   Endothelial dysfunction - A marker of atherosclerotic risk [J].
Bonetti, PO ;
Lerman, LO ;
Lerman, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :168-175
[5]   KLF2 suppresses TGF-β signaling in endothelium through induction of Smad7 and inhibition of AP-1 [J].
Boon, Reinier A. ;
Fledderus, Joost O. ;
Volger, Oscar L. ;
van Wanrooij, Eva J. A. ;
Pardali, Evangelia ;
Weesie, Frank ;
Kuiper, Johan ;
Pannekoek, Hans ;
ten Dijke, Peter ;
Horrevoets, Anton J. G. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) :532-539
[6]   Macrophage metabolism in atherosclerosis [J].
Bories, Gael F. P. ;
Leitinger, Norbert .
FEBS LETTERS, 2017, 591 (19) :3042-3060
[7]   Vascular endothelium - Gatekeeper of vessel health [J].
Cahill, Paul A. ;
Redmond, Eileen M. .
ATHEROSCLEROSIS, 2016, 248 :97-109
[8]   Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives [J].
Chiu, Jeng-Jiann ;
Chien, Shu .
PHYSIOLOGICAL REVIEWS, 2011, 91 (01) :327-387
[9]   Mitohormesis in Mice via Sustained Basal Activation of Mitochondrial and Antioxidant Signaling [J].
Cox, Carly S. ;
McKay, Sharen E. ;
Holmbeck, Marissa A. ;
Christian, Brooke E. ;
Scortea, Andrew C. ;
Tsay, Annie J. ;
Newman, Laura E. ;
Shadel, Gerald S. .
CELL METABOLISM, 2018, 28 (05) :776-+
[10]   Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease [J].
Fernández-Hernando, Carlos ;
Ackah, Eric ;
Yu, Jun ;
Suarez, Yajaira ;
Murata, Takahisa ;
Iwakiri, Yasuko ;
Prendergast, Jay ;
Miao, Robert Q. ;
Birnbaum, Morris J. ;
Sessa, William C. .
CELL METABOLISM, 2007, 6 (06) :446-457